Centene Newsroom

Elevance Extends Losses as BofA Cuts on Medicaid Headwinds

Seeking AlphaJul 18 10:27 ET

Centene Analyst Ratings

BenzingaJul 15 10:01 ET

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Centene (CNC) and Radnet (RDNT)

TipRanksJul 11 08:36 ET

Jefferies Adjusts Price Target on Centene to $83 From $90

MT NewswiresJul 11 08:02 ET

The Latest Analyst Ratings For Centene

BenzingaJul 10 13:02 ET

Centene Analyst Ratings

BenzingaJul 10 12:42 ET

JPMorgan Adjusts Price Target on Centene to $80 From $85

MT NewswiresJul 10 09:42 ET

Centene (CNC) Gets a Buy From Barclays

TipRanksJul 10 05:01 ET

Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating

MT NewswiresJun 27 07:09 ET

Navigating 11 Analyst Ratings For Centene

BenzingaJun 21 13:00 ET

Centene Analyst Ratings

BenzingaJun 21 12:52 ET

Centene Analyst Ratings

BenzingaJun 12 12:27 ET

Stephens Adjusts Price Target on Centene to $77 From $83

MT NewswiresMay 31 10:24 ET

Centene Analyst Ratings

BenzingaMay 30 12:01 ET

What 11 Analyst Ratings Have To Say About Centene

BenzingaMay 30 10:00 ET

Oppenheimer Remains a Buy on Centene (CNC)

TipRanksMay 30 08:04 ET

Analysts Offer Insights on Healthcare Companies: Centene (CNC), Zimmer Biomet Holdings (ZBH) and Madrigal Pharmaceuticals (MDGL)

TipRanksMay 30 06:13 ET

Centene Analyst Ratings

BenzingaMay 30 05:50 ET

Baird Initiates Coverage On Centene With Neutral Rating, Announces Price Target of $83

BenzingaMay 30 05:50 ET

Centene Analyst Ratings

BenzingaMay 2 10:42 ET